Bosentan induces clinical and hemodynamic improvement in candidates for right-sided heart bypass surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 2, 2010, Pages 346-351

  Hirono, Keiichi ^a   Yoshimura, Naoki ^a   Taguchi, Masato ^a   Watanabe, Kazuhiro ^a   Nakamura, Tsuneyuki ^b   Ichida, Fukiko ^a   Miyawaki, Toshio ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

CHD; congenital heart disease; New York University Pediatric Heart Failure Index; NYUPHFI; PAH; PAP; pulmonary artery hypertension; pulmonary artery pressure; pulmonary vascular resistance; PVR; single ventricle; SV

Indexed keywords

BOSENTAN;

ARTICLE; BLALOCK TAUSSIG SHUNT; BYPASS SURGERY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUSHING; FONTAN PROCEDURE; GLENN SHUNT; HEART SINGLE VENTRICLE; HEART SURGERY; HEMODYNAMICS; HUMAN; INFANT; LIVER FUNCTION TEST; LUNG ARTERY BANDING; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; NOSE CONGESTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RIGHT SIDED HEART BYPASS SURGERY; SIDE EFFECT; SYSTEMIC VASCULAR RESISTANCE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHILD, PRESCHOOL; FEMALE; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; PULMONARY ARTERY; SULFONAMIDES; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 77955472440     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.03.023     Document Type: Article

References (24)

1. N. Galiè, A. Torbicki, R. Barst, P. Dartevelle, S. Haworth, and T. Higenbottam et al. Guidelines on diagnosis and treatment of PAH. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology Eur Heart J 25 2004 2243 2278
2. L.J. Rubin, D.B. Badesch, R.J. Barst, N. Galie, C.M. Black, and A. Keogh Bosentan therapy for pulmonary arterial hypertension N Engl J Med 346 2002 896 903 (Pubitemid 34984638)
3. N. Galiè, W. Seeger, R. Naeije, G. Simonneau, and L.J. Rubin Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension J Am Coll Cardiol 43 2004 81 88S
4. R.N. Channick, G. Simonneau, O. Sitbon, I.M. Robbins, A. Frost, and V.F. Tapson Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study Lancet 358 2001 1119 1123 (Pubitemid 32971843)
5. M.A. Gatzoulis, P. Rogers, W. Li, C. Harries, D. Cramer, and S. Ward et al. Safety and tolerability of bosentan in adults with Eisenmenger physiology Int J Cardiol 98 2005 147 151
6. I. Schulze-Neick, N. Gilbert, R. Ewert, C. Witt, E. Gruenig, and B. Enke et al. Adult patients with congenital heart disease and pulmonary hypertension: first open prospective multicenter study of bosentan therapy Am Heart J 150 2005 716
7. N. Galiè, M. Beghetti, M.A. Gatzoulis, J. Granton, R.M. Berger, and A. Lauer et al. Bosentan therapy in patients with Eisenmenger syndrome. A multicenter, double-blind, randomized, placebo controlled study Circulation 114 2006 48 54
8. S.C. Apostolopoulou, J. Papagiannis, and S. Rammos Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation J Heart Lung Transplant 24 2005 1174 1176
9. J.K. Votava-Smith, G.S. Perens, and J.C. Alejos Bosentan for increased pulmonary vascular resistance in a patient with single ventricle physiology and a bidirectional Glenn shunt Pediatr Cardiol 28 2007 314 316
10. D. Connolly, M. Rutkowski, M. Auslender, and M. Artman The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children J Pediatr 138 2001 644 648
11. Bridges ND, O'Lauhlin MP, Mullins CE, Freed MD. In: Allen HD, Gutgesell HP, Clark EB, Driscoll DJ, eds. Moss and Adams Heart Disease in Infants, Children, and Adolescents. Cardiac catheterization, angiography, and intervention, Volume 1. Baltimore: Williams & Wilkins; 2001:276-324.
12. W. Grossman Clinical measurement of vascular resistance and assessment of vasodilator drugs W. Grossman, ed. Cardiac Catheterization and Angiography 1991 Lea and Febiger Philadelphia 143 151
13. A. Cloutier, J.M. Ash, J.F. Smallhorn, W.G. Williams, G.A. Trusler, and R.D. Rowe et al. Abnormal distribution of pulmonary blood flow after the Glenn shunt or Fontan procedure: risk of development of arteriovenous fistulae Circulation 72 1985 471 479
14. J.C. Alejos, R.G. Williams, J.M. Jarmakani, A.J. Galindo, J.B. Isabel-Jones, and D. Drinkwater et al. Factors influencing survival in patients undergoing the bidirectional Glenn anastomosis Am J Cardiol 75 1995 1048 1050
15. A.K. Pridjian, A.M. Mendelsohn, F.M. Lupinetti, R.H. Beekman 3rd, M. Dick 2nd, and G. Serwer et al. Usefulness of the bidirectional Glenn procedure as a staged reconstruction for the functional single ventricle Am J Cardiol 71 1993 959 962
16. J. Lutz, M. Gorenflo, M. Habighorst, M. Vogel, P.E. Lange, and B. Hocher Endothelin-1- and endothelin-receptors in lung biopsies of patients with pulmonary hypertension due to congenital heart disease Clin Chem Lab Med 37 1999 423 428
17. M. Yoshibayashi, K. Nishioka, K. Nakao, Y. Saito, M. Matsumura, and T. Ueda et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation Circulation 84 1991 2280 2285
18. S. Fratz, R. Geiger, H. Kresse, G. Roemer, M. Hennig, and W. Sebening et al. Pulmonary blood pressure, not flow, is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary vascular resistance J Thorac Cardiovasc Surg 126 2003 1724 1729
19. J.A. Vincent, R.D. Ross, J. Kassab, J.M. Hsu, and W.W. Pinsky Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood blow Am J Cardiol 71 1993 1204 1207
20. R.J. Barst, D. Ivy, J. Dingemanse, A. Widlitz, K. Schmitt, and A. Doran et al. Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension Clin Pharmacol Ther 73 2003 372 382
21. E.B. Rosenzweig, D.D. Ivy, A. Widlitz, A. Doran, L.R. Claussen, and D. Yung et al. Effects of long-term bosentan in children with pulmonary arterial hypertension J Am Coll Cardiol 46 2005 697 704
22. S. Maiya, A.A. Hislop, Y. Flynn, and S.G. Haworth Response to bosentan in children with pulmonary hypertension Heart 92 2006 664 670
23. T. Hiramatsu, Y. Imai, Y. Takanashi, K. Seo, M. Terada, and M. Aoki et al. Time course of endothelin-1 and adrenomedullin after the Fontan procedure Ann Thorac Surg 68 1999 169 172
24. K. Sakamoto, A. Ikai, Y. Fujimoto, and N. Ota Novel surgical approach 'intrapulmonary-artery septation' for Fontan candidates with unilateral pulmonary arterial hypoplasia or pulmonary venous obstruction Interact Cardiovasc Thorac Surg 6 2007 150 154